Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
32.53
-2.02 (-5.85%)
Feb 4, 2026, 12:56 PM EST - Market open
Oruka Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$49.73
Upside
+52.87%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $42 → $45 | Buy | Maintains | $42 → $45 | +38.33% | Jan 13, 2026 |
| BTIG | BTIG | Strong Buy Maintains $63 → $73 | Strong Buy | Maintains | $63 → $73 | +124.41% | Jan 12, 2026 |
| UBS | UBS | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +53.70% | Jan 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $75 | Buy | Initiates | $75 | +130.56% | Dec 18, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +38.33% | Nov 13, 2025 |
| BTIG | BTIG | Strong Buy Maintains $56 → $63 | Strong Buy | Maintains | $56 → $63 | +93.67% | Nov 13, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +84.45% | Oct 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $45 → $40 | Strong Buy | Maintains | $45 → $40 | +22.96% | Oct 27, 2025 |
| Barclays | Barclays | Buy Initiates $48 | Buy | Initiates | $48 | +47.56% | Oct 13, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +72.15% | Sep 29, 2025 |
| BTIG | BTIG | Strong Buy Maintains $44 → $56 | Strong Buy | Maintains | $44 → $56 | +72.15% | Sep 17, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $46 | Strong Buy | Maintains | $46 | +41.41% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +38.33% | Aug 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +38.33% | Jul 23, 2025 |
| Wedbush | Wedbush | Buy Reiterates $40 | Buy | Reiterates | $40 | +22.96% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +38.33% | Feb 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.